StockData
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO) stock

BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3060% above fair value
$358.19−2.07 (-0.57%)

Close on Nov 17, 2026Market cap $9.74BP/E 44.1Yield –

Bio-Rad Laboratories market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bio-Rad Laboratories's market cap was $10.39B on Nov 11, 2026, against $8.94B a year earlier. Over the last 5 years it ranged from $6.37B to $22.82B, with a median of $9.80B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$10.39B+24.6%
2025Dec 31, 2025$8.34B-10.7%
2024Dec 31, 2024$9.34B-2.0%
2023Dec 29, 2023$9.53B-24.3%
2022Dec 30, 2022$12.59B-44.8%
2021Dec 31, 2021$22.82B+29.7%
2020Dec 31, 2020$17.59B+58.0%
2019Dec 31, 2019$11.13B+58.6%
2018Dec 31, 2018$7.02B-1.8%
2017Dec 29, 2017$7.15B+32.6%
2016Dec 30, 2016$5.39B+32.5%
2015Dec 31, 2015$4.07B+16.0%
2014Dec 31, 2014$3.51B-1.4%
2013Dec 31, 2013$3.55B+18.4%
2012Dec 31, 2012$3.00B+10.1%
2011Dec 30, 2011$2.73B-6.5%
2010Dec 31, 2010$2.92B+9.4%
2009Dec 31, 2009$2.67B–

More Bio-Rad Laboratories figures

See a number that looks wrong?